Acute Atherosis of the Uterine Spiral Arteries: Clinicopathologic Implications

다국어 초록 (Multilingual Abstract)

Acute atherosis is unique vascular changes of the placenta associated with poor placentation. It is characterized by subendothelial lipid-filled foam cells, fibrinoid necrosis of the arterial wall, perivascular lymphocytic infiltration, and it is histologically similar to early-stage atherosclerosis. Acute atherosis is rare in normal pregnancies, but is frequently observed in non- transformed spiral arteries in abnormal pregnancies, such as preeclampsia, small for gestational age (SGA), fetal death, spontaneous preterm labor and preterm premature rupture of membranes. In preeclampsia, spiral arteries fail to develop physiologic transformation and retain thick walls and a narrow lumen. Failure of physiologic transformation of spiral arteries is believed to be the main cause of uteroplacental ischemia, which can lead to the production of anti-angiogenic factors and induce endothelial dysfunction and eventually predispose the pregnancy to preeclampsia. Acute atherosis is more frequently observed in the spiral arteries of the decidua of the placenta (parietalis or basalis) than in the decidual or myometrial segments of the placental bed. The presence and deeper location of acute atherosis is associated with poorer pregnancy outcomes, more severe disease, earlier onset of preeclampsia, and a greater frequency of SGA neonates in patients with preeclampsia. Moreover, the idea that the presence of acute atherosis in the placenta may increase the risk of future cardiovascular disease in women with a history of preeclampsia is of growing concern. Therefore, placental examination is crucial for retrospective investigation of pregnancy complications and outcomes, and accurate placental pathology based on universal diagnostic criteria in patients with abnormal pregnancies is essential for clinicopathologic correlation.

참고문헌 (Reference)

• 1 Kocyigit Y, "cytokines and lipoprotein in pre-eclamptic and normotensive pregnant women" 19 : 267-273, 2004
• 2 Kusanovic JP, "but decreased in preeclampsia and small for gestational age pregnancies" 20 : 867-878, 2007
• 3 Kim CJ, "and pathological features of chronic chorioamnionitis : a lesion associated with spontaneous preterm birth" 23 : 1000-1011, 2010
• 4 Hertig AT, "Vascular pathology in the hypertensive albuminuric toxemias of pregnancy" 4 : 602-614, 1945
• 5 Zeek PM, "Vascular changes in the decidua associated with eclamptogenic toxemia of pregnancy" 20 : 1099-1109, 1950
• 6 Robertson WB, "Uteroplacental vascular pathology" 5 : 47-65, 1975
• 7 Makris A, "Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1" 71 : 977-984, 2007
• 8 Gilstrap LC, "Urinary tract infections in women" 2 : 643-648, 1990
• 9 Levine RJ, "Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia" 190 : 707-713, 2004
• 10 Lau SY, "Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis" 70 : 412-427, 2013
• 11 Kim YM, "Toll-like receptor 4: a potential link between “danger signals,” the innate immune system, and preeclampsia?" 193 (193): 921-927, 2005
• 12 Erez O, "Tissue factor and its natural inhibitor in pre-eclampsia and SGA" 21 : 855-869, 2008
• 13 Brosens I, "The"Great Obstetrical Syndromes"are associated with disorders of deep placentation" 204 : 193-201, 2011
• 14 Freese UE, "The uteroplacental vascular relationship in the human" 101 : 8-16, 1968
• 15 Pijnenborg R, "The uterine spiral arteries in human pregnancy : facts and controversies" 27 : 939-958, 2006
• 16 De Wolf F, "The ultrastructure of acute atherosis in hypertensive pregnancy" 123 : 164-174, 1975
• 17 Ismail MA, "The significance of C-reactive protein levels in women with premature rupture of membranes" 151 : 541-544, 1985
• 18 Brosens IA, "The role of the spiral arteries in the pathogenesis of preeclampsia" 1 : 177-191, 1972
• 19 McFadyen IR, "The relation of birthweight to histological appearances in vessels of the placental bed" 93 : 476-481, 1986
• 20 Khong TY, "The placenta in maternal hyperhomocysteinaemia" 106 : 273-278, 1999
• 21 Brosens I, "The physiological response of the vessels of the placental bed to normal pregnancy" 93 : 569-579, 1967
• 22 Driscoll SG, "The pathology of pregnancy complicated by diabetes mellitus" 49 : 1053-1067, 1965
• 23 Robertson WB, "The pathological response of the vessels of the placental bed to hypertensive pregnancy" 93 : 581-592, 1967
• 24 Boyd EM, "The lipemia of pregnancy" 13 : 347-363, 1934
• 25 Sahin S, "The impact of platelet functions and inflammatory status on the severity of preeclampsia" 28 : 643-648, 2015
• 26 Hansson GK, "The immune response in atherosclerosis : a double-edged sword" 6 : 508-519, 2006
• 27 Potter JM, "The hyperlipidemia of pregnancy in normal and complicated pregnancies" 133 : 165-170, 1979
• 28 Kim YM, "The frequency of acute atherosis in normal pregnancy and preterm labor, preeclampsia, small-for-gestational age, fetal death and midtrimester spontaneous abortion" 28 : 2001-2009, 2015
• 29 Moldenhauer JS, "The frequency and severity of placental findings in women with preeclampsia are gestational age dependent" 189 : 1173-1177, 2003
• 30 Gotsch F, "The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection/inflammation, and spontaneous parturition at term: a role for interleukin-10" 21 : 529-547, 2008
• 31 Venkatesha S, "Soluble endoglin contributes to the pathogenesis of preeclampsia" 12 : 642-649, 2006
• 32 Coata G, "Soluble adhesion molecules: marker of pre-eclampsia and intrauterine growth restriction" 12 : 28-34, 2002
• 33 Chaiworapongsa T, "Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia" 12 : 19-27, 2002
• 34 Stampalija T, "Soluble ST2, a modulator of the inflammatory response, in preterm and term labor" 27 : 111-121, 2014
• 35 Belo L, "Similarities between pre-eclampsia and atherosclerosis: a protective effect of physical exercise?" 15 : 2223-2229, 2008
• 36 Freeman DJ, "Short-and long-term changes in plasma inflammatory markers associated with preeclampsia" 44 : 708-714, 2004
• 37 Berends AL, "Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease" 51 : 1034-1041, 2008
• 38 Kim MA, "Serum markers for prediction of spontaneous preterm delivery in preterm labour" 41 : 773-780, 2011
• 39 Loukovaara MJ, "Serum highly sensitive C-reactive protein in preterm premature rupture of membranes" 110 : 26-28, 2003
• 40 Yoon BH, "Serum C-reactive protein, white blood cell count, and amniotic fluid white blood cell count in women with preterm premature rupture of membranes" 88 : 1034-1040, 1996
• 41 Lorentzen B, "Sera from preeclamptic women increase the content of triglycerides and reduce the release of prostacyclin in cultured endothelial cells" 63 : 363-372, 1991
• 42 Staff AC, "Review: preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: two new hypotheses" 34 (34): S73-S78, 2013
• 43 Hanssens M, "Renin-like immunoreactivity in uterus and placenta from normotensive and hypertensive pregnancies" 81 : 177-184, 1998
• 44 Duff P, "Pyelonephritis in pregnancy" 27 : 17-31, 1984
• 45 Libby P, "Progress and challenges in translating the biology of atherosclerosis" 473 : 317-325, 2011
• 46 Sexton LI, "Premature separation of the normally implanted placenta; a clinicopathological study of 476 cases" 59 : 13-24, 1950
• 47 Redman CW, "Preeclampsia: an excessive maternal inflammatory response to pregnancy" 180 (180): 499-506, 1999
• 48 Staff AC, "Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors" 101-102 : 120-126, 2014
• 49 Soto E, "Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products" 23 : 646-657, 2010
• 50 Serin IS, "Predictive value of tumor necrosis factor alpha (TNF-alpha) in preeclampsia" 100 : 143-145, 2002
• 51 Chaiworapongsa T, "Pre-eclampsia part 1: current understanding of its pathophysiology" 10 : 466-480, 2014
• 52 Roberts JM, "Pre-eclampsia : more than pregnancy-induced hypertension" 341 : 1447-1451, 1993
• 53 Steegers EA, "Pre-eclampsia" 376 : 631-644, 2010
• 54 Pitiphat W, "Plasma C-reactive protein in early pregnancy and preterm delivery" 162 : 1108-1113, 2005
• 55 Ogishima D, "Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies" 50 : 224-229, 2000
• 56 Salafia CM, "Placental pathology in systemic lupus erythematosus and phospholipid antibody syndrome" 23 : 85-97, 1997
• 57 Maqueo M, "Placental pathology in eclampsia and preeclampsia" 24 : 350-356, 1964
• 58 Labarrere CA, "Placental lesions in maternal autoimmune diseases" 12 : 78-86, 1986
• 59 Kim YM, "Placental lesions associated with acute atherosis" 28 : 1554-1562, 2015
• 60 Nayar R, "Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome; a case report and review of the literature" 27 : 201-206, 1996
• 61 Brosens I, "Placental bed disorders" Cambridge University Press 11-, 2010
• 62 Small DM, "Physical-chemical basis of lipid deposition in atherosclerosis" 185 : 222-229, 1974
• 63 Gervasi MT, "Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia" 185 : 792-797, 2001
• 64 Naccasha N, "Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection" 185 : 1118-1123, 2001
• 65 Gervasi MT, "Phenotypic and metabolic characteristics of maternal monocytes and granulocytes in preterm labor with intact membranes" 185 : 1124-1129, 2001
• 66 Cruciani L, "Pentraxin 3 in maternal circulation: an association with preterm labor and preterm PROM, but not with intra-amniotic infection/inflammation" 23 : 1097-1105, 2010
• 67 Fox H, "Pathology of theplacenta" Saunders-Elsevier 147-186, 2007
• 68 Brosens I, "On the pathogenesis of placental infarcts in pre-eclampsia" 79 : 794-799, 1972
• 69 Rocha VZ, "Obesity, inflammation, and atherosclerosis" 6 : 399-409, 2009
• 70 Sacks GP, "Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis" 179 : 80-86, 1998
• 71 Espinoza J, "Normal and abnormal transformation of the spiral arteries during pregnancy" 34 : 447-458, 2006
• 72 Johnston TA, "Neutrophil activation in small for gestational age pregnancies" 98 : 105-106, 1991
• 73 Sabatier F, "Neutrophil activation in preeclampsia and isolated intrauterine growth restriction" 183 : 1558-1563, 2000
• 74 Belo L, "Neutrophil activation and C-reactive protein concentration in preeclampsia" 22 : 129-141, 2003
• 75 Emmrich P, "Morphology of myometrial and de cidual arteries in normal pregnancy, in toxemia of pregnancy, and in maternal diabetes (author’s transl)" 43 : 38-61, 1975
• 76 Gerretsen G, "Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation" 88 : 876-881, 1981
• 77 Brosens IA, "Morphological changes in the utero-placental bed in pregnancy hypertension" 4 : 573-593, 1977
• 78 Hustin J, "Maternal vascular lesions in pre-eclampsia and intrauterine growth retardation: light microscopy and immunofluorescence" 4 : 489-498, 1983
• 79 Althabe O, "Maternal vascular lesions in placentae of small-for-gestational-age infants" 6 : 265-276, 1985
• 80 Robertson WB, "Maternal uterine vascular lesions in the hypertensive complications of pregnancy" 5 : 115-127, 1976
• 81 Gulati S, "Maternal serum interleukin-6 and its association with clinicopathological infectious morbidity in preterm premature rupture of membranes : a prospective cohort study" 25 : 1428-1432, 2012
• 82 Baker AM, "Maternal serum dyslipidemia occurs early in pregnancy in women with mild but not severe preeclampsia" 201 : 293.e1-293.e4, 2009
• 83 Moghaddam Banaem L, "Maternal serum C-reactive protein in early pregnancy and occurrence of preterm premature rupture of membranes and preterm birth" 38 : 780-786, 2012
• 84 Enquobahrie DA, "Maternal plasma transforming growth factor-beta1 concentrations in preeclamptic and normotensive pregnant Zimbabwean women" 17 : 343-348, 2005
• 85 Sibai B, "Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia" 200 : 630.e1-630.e8, 2009
• 86 Stampalija T, "Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia" 26 : 1359-1370, 2013
• 87 Chaiworapongsa T, "Maternal lymphocyte subpopulations(CD45RA+ and CD45RO+)in preeclampsia" 187 : 889-893, 2002
• 88 Gervasi MT, "Maternal intravascular inflammation in preterm premature rupture of membranes" 11 : 171-175, 2002
• 89 Laskowska M, "Maternal and umbilical sTNF-R1 in preeclamptic pregnancies with intrauterine normal and growth retarded fetus" 26 : 13-21, 2007
• 90 Lee J, "Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis : evidence in support of the chronic nature of maternal anti-fetal rejection" 66 : 510-526, 2011
• 91 Twina G, "Lower circulation levels and activity of alpha-1 antitrypsin in pregnant women with severe preeclampsia" 25 : 2667-2670, 2012
• 92 Sattar N, "Lipoprotein subfraction concentrations in preeclampsia : pathogenic parallels to atherosclerosis" 89 : 403-408, 1997
• 93 Ogge G, "Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia" 23 : 476-487, 2010
• 94 Sharma A, "Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women" 58 : 21-30, 2007
• 95 Libby P, "Leducq Transatantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice" 54 : 2129-2138, 2009
• 96 Staff AC, "Learning from the placenta : acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health" 56 : 1026-1034, 2010
• 97 Redman CW, "Latest advances in understanding preeclampsia" 308 : 1592-1594, 2005
• 98 Labarrere CA, "Intrauterine growth retardation of unknown etiology: II. Serum complement and circulating immune complexes in maternal sera and their relationship with parity and chronic villitis" 12 : 4-6, 1986
• 99 Labarrere C, "Intrauterine growth retardation of unknown etiology. I. Serum complement and circulating immune complexes in mothers and infants" 8 : 87-93, 1985
• 100 Vince GS, "Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia" 102 : 20-25, 1995
• 101 Packard RR, "Innate and adaptive immunity in atherosclerosis" 31 : 5-22, 2009
• 102 Libby P, "Inflammatory mechanisms: the molecular basis of inflammation and disease" 65 (65): S140-S146, 2007
• 103 Libby P, "Inflammation in atherosclerosis : transition from theory to practice" 74 : 213-220, 2010
• 104 Libby P, "Inflammation in atherosclerosis" 420 : 868-874, 2002
• 105 Legein B, "Inflammation and immune system interactions in atherosclerosis" 70 : 3847-3869, 2013
• 106 Rosenfeld ME, "Inflammation and atherosclerosis : direct versus indirect mechanisms" 13 : 154-160, 2013
• 107 Libby P, "Inflammation and atherosclerosis" 105 : 1135-1143, 2002
• 108 Soto E, "Increased concentration of the complement split product C5a in acute pyelonephritis during pregnancy" 17 : 247-252, 2005
• 109 Hayati AR, "Incidence of acute atherosis in complete molar pregnancy" 20 : 113-114, 1998
• 110 Khong TY, "Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants" 93 : 1049-1059, 1986
• 111 Woollard KJ, "Immunological aspects of atherosclerosis" 125 : 221-235, 2013
• 112 Pijnenborg R, "Immunolocalization of tumour necrosis factor-alpha(TNF-alpha)in the placental bed of normotensive and hypertensive human pregnancies" 19 : 231-239, 1998
• 113 Labarrere C, "Immunohistochemical findings in acute atherosis associated with intrauterine growth retardation" 7 : 149-155, 1985
• 114 Meekins JW, "Immunohistochemical detection of lipoprotein(a)in the wall of placental bed spiral arteries in normal and severe preeclamptic pregnancies" 15 : 511-524, 1994
• 115 Libby P, "Immune effector mechanisms implicated in atherosclerosis : from mice to humans" 38 : 1092-1104, 2013
• 116 Galkina E, "Immune and inflammatory mechanisms of atherosclerosis(*)" 27 : 165-197, 2009
• 117 Staff AC, "IFPA Award in Placentology Lecture: preeclampsia, the decidual battleground and future maternal cardiovascular disease" 35 (35): S26-S31, 2014
• 118 Frusca T, "Histological features of uteroplacental vessels in normal and hypertensive patients in relation to birthweight" 96 : 835-839,
• 119 Velzing-Aarts FV, "High serum interleukin-8 levels in afro-caribbean women with pre-eclampsia: relations with tumor necrosis factor-alpha, duffy negative phenotype and von Willebrand factor" 48 : 319-322, 2002
• 120 Faye-Petersen O, "Handbook of placental pathology" Taylor & Francis 53-78, 2006
• 121 Brenner B, "Haemostatic changes in pregnancy" 114 : 409-414, 2004
• 122 Mitchell RN, "Graft vascular disease : immune response meets the vessel wall" 4 : 19-47, 2009
• 123 De Wolf F, "Fetal growth retardation and the maternal arterial supply of the human placenta in the absence of sustained hypertension" 87 : 678-685, 1980
• 124 Brosens I, "Fetal growth retardation and the arteries of the placental bed" 84 : 656-663, 1977
• 125 Hubel CA, "Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum" 174 : 975-982, 1996
• 126 Kim YM, "Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes" 187 : 1137-1142, 2002
• 127 Kim YM, "Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes" 189 : 1063-1069, 2003
• 128 Sebire NJ, "Extravillus endovascular implantation site trophoblast invasion is abnormal in complete versus partial molar pregnancies" 22 : 725-728, 2001
• 129 Maynard SE, "Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia" 111 : 649-658, 2003
• 130 Bujold E, "Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin" 18 : 9-16, 2005
• 131 Hamai Y, "Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia" 38 : 89-93, 1997
• 132 Cetin I, "Elevated maternal levels of the long pentraxin 3(PTX3)in preeclampsia and intrauterine growth restriction" 194 : 1347-1353, 2006
• 133 Tjoa ML, "Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction" 59 : 29-37, 2003
• 134 Teran E, "Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia" 75 : 243-249, 2001
• 135 Johnson MR, "Does endothelial cell activation occur with intrauterine growth restriction?" 109 : 836-839, 2002
• 136 Mach F, "Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells" 104 : 1041-1050, 1999
• 137 Abramowsky CR, "Decidual vasculopathy of the placenta in lupus erythematosus" 303 : 668-672, 1980
• 138 Stevens DU, "Decidual vasculopathy in preeclampsia : lesion characteristics relate to disease severity and perinatal outcome" 34 : 805-809, 2013
• 139 De Wolf F, "Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant" 142 : 829-834, 1982
• 140 Kitzmiller JL, "Decidual arteriopathy in hypertension and diabetes in pregnancy : immunofluorescent studies" 141 : 773-779, 1981
• 141 Young JL, "Cytokines in the pathogenesis of atherosclerosis" 88 : 554-567, 2002
• 142 Jonsson Y, "Cytokine mapping of sera from women with preeclampsia and normal pregnancies" 70 : 83-91, 2006
• 143 Lain KY, "Contemporary concepts of the pathogenesis and management of preeclampsia" 287 : 3183-3186, 2002
• 144 Girardi G, "Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction" 203 : 2165-2175, 2006
• 145 Laskowska M, "Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation" 20 : 527-532, 2007
• 146 Sattar N, "Classic and novel risk factor parameters in women with a history of preeclampsia" 42 : 39-42, 2003
• 147 Conrad KP, "Circulating levels of immunoreactive cytokines in women with preeclampsia" 40 : 102-111, 1998
• 148 Szarka A, "Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array" 11 : 59-, 2010
• 149 Labarrere C, "Chronic villitis of unknown etiology and maternal arterial lesions in preeclamptic pregnancies" 20 : 1-11, 1985
• 150 Lee J, "Chronic chorioamnionitis is the most common placental lesion in late preterm birth" 34 : 681-689, 2013
• 151 Rajamäki K, "Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation" 5 : e11765-, 2010
• 152 van Rijn BB, "Cardiovascular disease risk factors in women with a history of early-onset preeclampsia" 121 : 1040-1048, 2013
• 153 Veerbeek JH, "Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension" 65 : 600-606, 2015
• 154 Braekke K, "Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia" 193 : 227-233, 2005
• 155 Watts DH, "C-reactive protein in normal pregnancy" 77 : 176-180, 1991
• 156 van Rijn BB, "C-reactive protein and fibrinogen levels as determinants of recurrent preeclampsia : a prospective cohort study" 32 : 408-414, 2014
• 157 Libby P., "Atherosclerosis: disease biology affecting the coronary vasculature" 98 : 3Q-96Q, 2006
• 158 Laudanski P, "Assessment of the selected biochemical markers in predicting preterm labour" 25 : 2696-2699, 2012
• 159 169. Labarrere CA, "Antigenic identification of cells in spiral artery trophoblastic invasion: validation of histologic studies by triple-antibody immunocytochemistry" 171 : 165-171, 1994
• 160 Sheppard BL, "An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation" 88 : 695-705, 1981
• 161 Ait-Oufella H, "Adaptive(T and B cells)immunity and control by dendritic cells in atherosclerosis" 114 : 1640-1660, 2014
• 162 Andersson J, "Adaptive immunity and atherosclerosis" 134 : 33-46, 2010
• 163 Labarrere CA, "Acute atherosis: a histopathological hallmark of immune aggression?" 9 : 95-108, 1988
• 164 Khong TY, "Acute atherosis in pregnancies complicated by hypertension, small-for-gestational-age infants, and diabetes mellitus" 115 : 722-725, 1991
• 165 Khong TY, "Acute atherosis in preeclampsia : maternal determinants and fetal outcome in the presence of the lesion" 157 : 360-363, 1987
• 166 Harsem NK, "Acute atherosis in decidual tissue : not associated with systemic oxidative stress in preeclampsia" 28 : 958-964, 2007
• 167 Meekins JW, "A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies" 101 : 669-674, 1994
• 168 Lee J, "A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d" 6 : e16806-, 2011
• 169 Kusanovic JP, "A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia" 22 : 1021-1038, 2009
• 170 Xie C, "A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia" 56 : 550-559, 2011